Figure 3 identifies the nine core targets of CDCA in the treatment of ALI as HSP90AA1, STAT3, HSP90AB1, EP300, NFKB1, CD4, NR1H4, MTOR, and TLR4. The gene discussed is NR1H4; the disease is acute respiratory distress syndrome.